Skip to main content
Log in

Quality of life of persons with onychomycosis

  • Research Papers
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Onychomycosis is a fungal infection of the nails which, although unsightly in appearance, is often considered to be a cosmetic problem. This research reports on the development and performance of a quality-of-life instrument to measure the impact of this disease on the patients' mental and general health, social functioning, pain, and self-confidence. In telephone interviews, 680 members of a health maintenance organization (299 with onychomycosis and 381 without) were asked a battery of items regarding quality of life (mental and social functioning, self-esteem, pain) and specific problems and symptoms related with one's nails. Persons with onychomycosis had significantly poorer ratings compared with the healthy persons with respect to general health (p=0.02) and bodily pain p<0.001). Persons with onychomycosis also had significantly (p<0.05) poorer ratings for mental health, social functioning, health concern, physical appearance, and functional limitations associated with activities involving standing on one's feet or working with one's fingers. This study is the first to document the impact of onychomycosis on an individual's quality of life. Persons with onychomycosis may adapt to this condition, but they continue to experience embarrassment and discomfort that reduces their quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. AndréJ, Achten G. Onychomycosis. Int J Dermatol 1987; 26: 481–490.

    Google Scholar 

  2. ZaiasN. The Nail in Health and Disease. New York: Appleton and Lange, 1990: 87.

    Google Scholar 

  3. BadenHP. Diseases of the Hair and Nails. New York: Yearbook Medical Publishers, 1987: 27.

    Google Scholar 

  4. DompmartinD, DompmartinA, DeluolAM, GrosshansE, CoulaudJP. Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients. Int J Dermatol 1990; 29: 337–339.

    Google Scholar 

  5. StaughtonR. Skin manifestations in AIDS patients. Br J Clin Pract 1990; 71 (Suppl.): 109–113.

    Google Scholar 

  6. AndersonD. Griseofulvin: biology and clinical usefulness. Ann Allergy 1965; 23: 103–110.

    Google Scholar 

  7. The Medical Letter on Drugs and Therapeutics. Issue 446, 1976: 18: 17–18.

  8. HayRJ. Fungal Infections and ageing. Br Med J 1983; 287: 666.

    Google Scholar 

  9. ArenasR, FernándezG, DomínguezL. Onychomycosis treated with Itraconazole or Griseofulvin alone with and without a topical antimycotic or keratolytic agent. Pharmacol Ther 1991; 30: 586–589.

    Google Scholar 

  10. ZaiasN. Management of onychomycosis with oral terbinafine. J Am Acad Dermatol 1990; 23: 810–812.

    Google Scholar 

  11. National Center for Health Statistics. National Health Interview Survey, 1983–1985. Washington, D.C.

  12. TarlovAR, WareJEJr, GreenfieldS, NelsonEC, PerrinE, ZubkoffM. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 1989; 262: 925–930.

    Google Scholar 

  13. WellsKB, StewartA, HaysRD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989; 262: 914–919.

    Google Scholar 

  14. StewartAL, HaysRD, WareJE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724–735.

    Google Scholar 

  15. FlemingJS, CourtneyBE. The dimensionality of self-esteem: II. Hierarchical facet model for revised measurement scales. J Pers Soc Psychol 1984; 46: 404–421.

    Google Scholar 

  16. SysteMetrics-McGraw Hill Report, June 22, 1990 to Sandoz Pharmaceuticals Corporation.

  17. SAS Institute Inc. SAS for Personal Computers, Release 6.03. Cary, NC, 1988.

  18. Technology Assessment Group. Quality of Life of Onychomycosis Patients. A comparative study of onychomycosis patients and healthy HMO enrollees. Report to Sandoz Pharmaceuticals Corp., June 1991. Data available upon request from the authors.

  19. BuxtonM, DrummondM. Quality of life measurement in the development of medicines. Pharm J 1990; 244: 260–262.

    Google Scholar 

  20. FreidenbergsI. Psychosocial management of patients with cutaneous cancers: A preliminary report. J Dermatol Surg Oncol 1981; 7: 828–830.

    Google Scholar 

  21. FavaGA, PeriniGI, SantonastasoP, Veller FornasaC. Life events and psychological distress in dermatologic disorders: Psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980; 53: 277–282.

    Google Scholar 

  22. FinlayAY, KhanGK, LuscombeDK, SalekMS. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 1990; 123: 751–756.

    Google Scholar 

  23. FinlayAY, KellySE. Psoriasis—An index of disability. Clin Exp Dermatol 1987; 12: 8–11.

    Google Scholar 

  24. GuptaMA, GuptaAK, EllisCN, VoorheesJJ. Some psychosomatic aspects of psoriasis. Adv Dermatol 1990, 5: 21–32.

    Google Scholar 

  25. RamsayB, O'ReaganM. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195–201.

    Google Scholar 

  26. Editorial. Onychomycosis and terbinafine. Lancet 1990; 335: 636.

Download references

Author information

Authors and Affiliations

Authors

Additional information

This research was supported through a research grant from Sandoz Research Institute to Technology Assessment Group, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lubeck, D.P., Patrick, D.L., McNulty, P. et al. Quality of life of persons with onychomycosis. Qual Life Res 2, 341–348 (1993). https://doi.org/10.1007/BF00449429

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00449429

Key words

Navigation